Tender Details
Check your funding eligibility in 2 minutes.
Answer a few questions and our team will contact you with your best options.
About Tender
💉 Procurement Opportunity For Insulin Degludec And Insulin Aspart Solutions 💉 The Ministry Of Railways, Specifically The Central Government Ministry/Department, Is Seeking Bids For The Supply Of Insulin Degludec And Insulin Aspart Solutions. The Solution Provided In A 3ml Penfill Cartridge Contains 100 Units Of Insulin Degludec And Insulin Aspart, With 70% Being Soluble Insulin Degludec And 30% Soluble Insulin Aspart, Equivalent To 2.56mg And 1.05mg Of Salt Free Anhydrous Insulin Degludec And Insulin Aspart, Respectively. 📅 Bid Submission Deadline: April 15, 2024, 10:30 Am Interested Bidders Are Requested To Submit Their Proposals By The Specified Deadline, Ensuring They Meet All The Technical And Financial Requirements As Outlined In The Tender Document. Keywords: Insulin Degludec, Insulin Aspart, Insulin Solution, Medical Tender, Ministry Of Railways, Central Government, Diabetes Care, Bid Submission| Particulars | Details |
|---|---|
| Title |
Insulin Degludec / Insulin Aspart (R Dna Origin) Solution For Subcutaneous Injection. 1ml Of The Solution Contains 100 Units Insulin Degludec And Insulin Aspart (70 Percent Soluble Insulin Degludec And 30 Percent Soluble Insulin Aspart) Equivalent To 2.56mg Salt Free Anhydrous Insulin Degludec And 1.05mg Salt Free Anhydrous Insulin Aspart In 3ml Penfill Cartridge.
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106307916 |
|
Reference Number |
08245042B |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | |
| Place | Bilaspur |
| Link | https://www.ireps.gov.in/ireps/supply/pdfdocs/042024/106307916/viewNitPdf_4527219.pdf |
| Start Date | April 02, 2024 21:42 |
| End Date |
15/04/2024 ( Expired 446 days ago ) Search Similar tenders? |
|
Join for More Relevant Opportunities |
Inj. insulin lispro 25 percent insulin lispro protamine suspension 75 percent (r-dna origin) - 100 iu/ml, 3 ml cartridge (01 pen 20 needles free per 20 cartridges)
For complete deion and other details, please refer to tender
Read moreInsulin degludec 2.56 mg (70 percent ) and insulin aspart 1.05 mg (30 percent ), 100 iu/ml, 3 ml penfil (ryzodeg penfill 3ml)
For complete deion and other details, please refer to tender
Read moreA m i no. 12.06 / 2025-26 insulin aspart and insulin degludec inj 30/70 100iu per ml in 3ml cartridge (intermediate acting insulin)
For complete deion and other details, please refer to tender
Read moreInsulin aspart 30 percent and insulin aspart protamine 70 percent 100iu/ml penfill injection . quote its brand name formula & life
For complete deion and other details, please refer to tender
Read moreGtl_medicine_(ph no.:10046) human insulin analogue inj (biosynthetic r-dna origin) soluble insulin aspart 100 iu/ml in 3.0 ml precision delivery device flexpens
For complete deion and other details, please refer to tender
Read moreProcurement of insulin aspart r - dna origin and degludec solution 30/70 100 iu/ml penfills
For complete deion and other details, please refer to tender
Read moreInsulin degludec (r dna origin) 100 iu/ml, 3ml cartridge (one pen and 20 needles free per 20 cartridges)
For complete deion and other details, please refer to tender
Read moreInsulin lispro biphasic containing 25 percent insulin lispro & 75 percent insulin lispro protamine suspension (r-dna origin) 3 ml cartridge (01 pen 20 needles free per 20 cartridges)
For complete deion and other details, please refer to tender
Read moreInsulin degludec 100 iu/ml(r-dna origin) in 3ml pre-filled pen
For complete deion and other details, please refer to tender
Read moreBiphasic insulin aspart (mixture of 30 percent soluble insulin aspart and 70 percent protamine crystallised insulin aspart) injection 100 u/ml, 03 ml cartridges. on each 6 cartidges one pen free .
For complete deion and other details, please refer to tender
Read moreof your Industry type